BioSpace News Archive

Drug Development

Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates to address the world’s most life-threatening diseases and public health threats, today announced positive preclinical data from its second-generation, protein-based COVID-19 vaccine candidate, a modified B.1.351 Spike (S)-Trimer

May 17, 2021
·
6 min read
Deals

Orion Biotech Opportunities Corp. Announces Closing of $200 Million Initial Public Offering of Securities

Orion Biotech Opportunities Corp. (the “Company”) today announced the closing of its initial public offering (“IPO”) of 20,000,000 units at a price of $10.00 per unit, resulting in total gross proceeds of $200,000,000

May 17, 2021
·
4 min read